Endocrine Testing Market 2025 to 2034

Endocrine Testing Market 2025 to 2034

Endocrine Testing Market (By Test Type: Estradiol (E2) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Cortisol Test, Insulin Test, Others; By Technology: Immunoassay, Chromatography, Mass Spectroscopy, Nucleic Acid Based; By End-User: Hospitals, Commercial Laboratories, Ambulatory Care Centers, Others; By Region: North America, LAMEA, Europe, Asia-Pacific) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034

Report ID: 11907 | Format: Databook | Published: January 2026 | Delivery: Immediate
Download Sample     Customisation Request  

Revenue, 2025

USD 15.63 

Forecast Year, 2034

USD 32.83 Bn

CAGR, 2025 - 2034

8.60%

Report Coverage

Worldwide

Published By

Saurabh Bidwai

Reviewed By

Aditi Shivarkar

Reviewed By

Aman Singh

The global endocrine testing market, valued at USD 15.63 billion in 2025, is projected to reach USD 32.83 billion by 2034, expanding at a CAGR of 8.6%, driven by rising hormonal disorders, advanced diagnostics, and growing healthcare awareness.

Endocrine Testing Market Size Analysis

Endocrine Testing Market Size By Test Type 2025 to 2034 (USD Billion)

Test Type 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Estradiol (E2) Test0.200.220.240.260.280.310.330.360.390.42
Dehydroepiandrosterone Sulfate (DHEAS) Test0.400.440.470.520.560.610.660.720.780.84
Progesterone Test0.600.650.710.770.840.910.991.071.171.27
Testosterone Test0.800.870.951.031.121.211.311.431.551.69
Thyroid Stimulating Hormone (TSH) Test1.001.091.181.281.401.511.641.791.942.11
Prolactin Test1.201.311.421.541.671.821.972.142.332.53
Follicle Stimulating Hormone (FSH) Test1.401.521.651.801.952.122.302.502.722.95
Human Chorionic Gonadotropin (hCG) Hormone Test1.601.741.892.052.232.422.632.853.103.37
Luteinizing Hormone (LH) Test1.801.962.132.312.512.722.963.213.493.79
Cortisol Test2.002.182.362.562.793.023.283.573.884.21
Insulin Test2.202.392.602.823.073.333.613.924.264.63
Others2.402.612.833.083.343.633.944.284.645.05

Endocrine Testing Market Size By Technology 2025 to 2034 (USD Billion)

Technology 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Immunoassay1.581.701.852.022.182.362.582.813.043.33
Chromatography3.133.403.704.024.344.725.155.576.056.55
Mass Spectroscopy4.695.095.525.996.537.097.698.369.069.83
Nucleic Acid Based6.236.787.367.998.699.4310.2211.1112.0813.12

Endocrine Testing Market Size By End User 2025 to 2034 (USD Billion)

End User 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Hospitals1.571.701.862.012.202.392.572.813.073.30
Commercial Laboratories3.143.413.704.024.364.705.145.586.056.60
Ambulatory Care Centers4.685.095.526.006.497.107.708.349.049.83
Others6.246.777.367.988.689.4210.2311.1112.0813.11

Endocrine Testing Market Size By Region 2025 to 2034 (USD Billion)

Region 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
North America1.571.711.852.022.182.392.572.783.023.32
LAMEA3.143.393.714.024.354.715.165.596.056.59
Europe4.705.095.546.006.517.107.688.359.099.83
Asia-Pacific6.236.797.357.998.699.4110.2311.1212.0913.11

Endocrine Testing Market Size to Hit USD 32.83 Billion by 2034

The global endocrine testing market size accounted for USD 15.63 billion in 2025 and is predicted to touch around USD 32.83 billion by 2034 with a growing at a CAGR of 8.60%.

Our Client